Status: Not yet recruiting
A Real World Study of Participants With Non-Small Cell Lung Cancer (NSCLC) With Epidermal Growth Factor Receptor Mutation (EGFRm)
This study aims to better understand people who have advanced or metastatic non-small cell lung cancer (NSCLC) with an EGFR mutation. NSCLC is an advanced stage cancer of the lung, occurring due to mutations (changes) in the EGFR gene. The study will assess the participant demographic background (that is age, gender etc.), the treatments they receive, how well those treatments work, and their health outcomes.
Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Janssen-Cilag Farmaceutica Ltda.Updated: Jul 2, 2026
Eligibility criteria
Histologically or cytologically confirmed diagnosis of advanced or metastatic un... [+1]
Participants who received any systemic cancer treatment outside the participatin... [+2]